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Article
Multiple sclerosis (MS) is an inflammatory, demyelinating 
disease of the central nervous system with an unknown etiol-
ogy that affects more than two million individuals worldwide 
(Multiple Sclerosis International Federation, 2013). Research 
on the natural history of MS paints a picture of a disease with 
different trajectories (Debouverie, Pittion-Vouyovitch, 
Louis, & Guillemin, 2008). However, 80% of MS patients 
have a walking impairment within 10 to 15 years of disease 
onset (Souza et al., 2010), and 50% of these patients require 
ambulatory assistance in another 5 years (i.e., within 15–20 
years of disease onset), even though disease progression 
might be slowing down (Tremlett, Zhao, Rieckmann, & 
Hutchinson, 2010). The risk of all-cause mortality in MS 
patients is two to three times that in the general population 
(Kingwell et al., 2012). The global economic and human 
costs of MS are high. In the United States alone, the total 
annual expenditures attributable to MS are estimated at 
US$billion (National Multiple Sclerosis Society [NMSS], 
2013a).
Disease-modifying therapies diminish the frequency and 
severity of relapses, decelerate the progression of disability, 
decrease the number of brain lesions, and enhance the qual-
ity of life of MS patients (Goodin et al., 2002). However, 
there is no cure for MS (NMSS, 2013b). Consequently, MS 
patients often resort to complementary and alternative medi-
cine (CAM) in the hope of obtaining an effective treatment 
(Olsen, 2009). In fact, despite the lack of conclusive empiri-
cal evidence supporting the usefulness of several CAM 
modalities for the treatment of MS (Bowling, 2011; Namaka 
et al., 2008), this patient population has a widespread pattern 
of CAM use (Stoll, Nieves, Tabby, & Schwartzman, 2012). 
In the past, the MS community at large has eagerly tried con-
troversial and unsubstantiated remedies, such as bee-venom 
therapy (Wesselius et al., 2005).
In 2009, the news of a novel theory on the nature of MS, 
which was proposed by the Italian physician and researcher 
Paolo Zamboni, captured the attention of international media 
outlets. Zamboni reported that MS might be the result of 
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chronic inadequate venous flow in the central nervous sys-
tem and can be alleviated by a procedure that was coined by 
him as the “liberation procedure” (Zamboni, Galeotti, 
Menegatti, Malagoni, Gianesini, et al., 2009; Zamboni, 
Galeotti, Menegatti, Malagoni, Mascoli, et al., 2009; 
Zamboni, Galeotti, Menegatti, Malagoni, Tacconi, et al., 
2009). On November 21, 2009, the Canadian Television 
Network (CTV) aired a special program about the liberation 
procedure in its award-winning documentary show called 
W5 (Favaro & St. Philip, 2009; “Kevin Newman,” 2014).
Since 2009, in the absence of scientific evidence demon-
strating the efficacy of the liberation procedure for the treat-
ment of MS, thousands of MS patients worldwide have 
undergone the new experimental procedure (O’Neill, 
Mazanderani, & Powell, 2012; Pryse-Phillips, Stefanelli, 
Murphy-Peddle, & Barrett, 2013). During the exodus of MS 
patients to the small number of countries that offer the 
unproven and radical liberation procedure, such as Costa 
Rica and Poland, authors of professional publications and the 
mass media reported on the fatal complications of the proce-
dure and issued medical warnings (Alphonso, 2010; 
American Neurological Association, 2010; Mansour et al., 
2010). Nevertheless, many individuals who could either 
afford or raise funds for the expensive procedure (i.e., up to 
tens of thousands of dollars for the procedure alone) traveled 
abroad to undergo the procedure based on Zamboni’s highly 
speculative theory, which is called chronic cerebrospinal 
venous insufficiency (CCSVI; Mansour et al., 2010).
MS patients give several reasons for seeking unconven-
tional treatments. Besides disillusionment with mainstream 
medication and medical care (Hussain-Gambles & Tovey, 
2004), we noted that negative characteristics of health care 
provider–patient relationships and communications were 
nestled among the most common reasons mentioned in the 
literature. For example, in explaining the rationale behind 
their decision to undergo CAM, MS patients cited poor 
patient–physician relationships (Mews & Zettl, 2012), brief 
medical consultations (Schwarz, Knorr, Geiger, & 
Flachenecker, 2008), and the lack of understanding and sup-
port from health care providers (Hussain-Gambles & Tovey, 
2004). Moreover, we identified calls in the literature for 
health care practitioners and researchers to communicate 
better with patients and the public about CAM in general 
(Gaylord & Mann, 2007) and the liberation procedure in par-
ticular (Pullman, Zarzeczny, & Picard, 2013); this would 
help the former in gaining insights on the perspectives of MS 
patients and facilitating informed patient decision making.
Given the high regard for nurses among the general popu-
lation (Swift, 2013), they play an important role in patient 
decision making in general (Say, Murtagh, & Thomson, 
2006). With a deeper understanding of the experience of 
decision making regarding the liberation procedure for MS 
patients, nurses and other health care practitioners can be 
more attuned to the perspectives of MS patients while help-
ing them in making informed decisions about the procedure. 
To our knowledge, however, there are no published qualita-
tive studies in this area till date; therefore, we set out in this 
study to answer the following research question:
Research Question 1: What is the experience of libera-
tion procedure decision making for persons living with 
MS?
Method
Given the abovementioned aim of our study, hermeneutic 
phenomenology was considered an appropriate methodology 
for this research. The aim of using hermeneutic phenomenol-
ogy is to gain a better understanding of the meaning or sig-
nificance of human lived experiences (van Manen, 1990), 
which generates practical knowledge and fosters reflective 
clinical practice (Bergum, 1991).
Setting and Participants
We conducted this study on the east coast of Canada, in the 
province of Newfoundland and Labrador (NL). The preva-
lence of MS in Canada is among the highest in the world 
(Beck, Metz, Svenson, & Patten, 2005; Marrie, Yu, 
Blanchard, Leung, & Elliott, 2010). In 2005, researchers cal-
culated the prevalence of MS in the Atlantic region of 
Canada, which includes NL, at 350 per 100,000 individuals 
(Beck et al., 2005).
The inclusion criteria for this study were English-speaking 
men and women aged 19 years or older, with a diagnosis of 
MS, and who considered whether or not to undergo the lib-
eration procedure. After ethical approval from the Health 
Research Ethics Board in St. John’s, NL, we recruited par-
ticipants through MS outpatient services. Health care provid-
ers or group facilitators in these clinical and support group 
settings informed potential participants about the study. The 
second author contacted individuals who were interested in 
participation, explained the study again to these potential 
participants, and arranged interviews with those who agreed 
to take part. A total of 15 adults (10 women and 5 men) were 
eventually included. We expected more women than men 
among the participants because the women-to-men MS ratio 
is approximately 3:1 (Marrie et al., 2010; Sloka, Pryse-
Phillips, & Stefanelli, 2005).
The participants were divided into three groups on the 
basis of their decisions regarding the liberation procedure. 
The first group included seven participants (five women, 
two men; mean age, 46 years; SD, 11 years) who immedi-
ately decided to undergo the liberation procedure. Three of 
these participants had a high school diploma, whereas four 
had received some postsecondary education. The second 
group included two participants (one woman, one man; 
mean age, 39 years; SD, 3 years) who decided to undergo 
the liberation procedure later; one had a high school 
diploma, and the other held a university degree. The third 
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group included six participants (four women, two men; 
mean age, 52 years; SD, 9 years) who decided against 
undergoing the liberation procedure; the two men had 
received some postsecondary education, and the four 
women held a university degree.
Data Collection
We collected data by conducting one face-to-face interview 
with all participants except one; we accommodated the 
wishes of this participant by conducting the interview over 
the telephone. The second author digitally recorded and 
conducted all interviews at a time and place chosen by each 
participant. As it turned out, all of the face-to-face inter-
views took place in the participants’ homes. The researcher 
obtained written informed consent before beginning each 
interview, including the telephone interview. Specifically, 
the researcher reviewed all sections of the consent form 
(e.g., purpose of the research, description of study proce-
dures, benefits and risks, privacy and confidentiality, the 
right to withdraw, permission to audio record the inter-
views) with each participant and answered their questions. 
Then, the researcher collected sociodemographic and 
MS-related medical information, including age, level of 
education, type of MS, length of time since diagnosis, and 
use of disease-modifying therapies, to describe the sample 
and help in interpreting the findings.
The second author initiated the interview with a broad, 
open-ended question that allowed the participant to talk 
freely about her or his experience with MS. Subsequently, 
the researcher posed follow-up, open-ended questions to 
explore the participant’s experience with the liberation pro-
cedure. The follow-up questions included the following: 
How did you find out about the liberation procedure? What 
do you think about the liberation procedure? How did you 
decide to have the liberation procedure? How did you decide 
to not have the liberation procedure? Who have you told 
about your decision to have/not have the procedure? How 
did they react?
Although an interview guide that included possible ques-
tions for the participants was developed, the interviews were 
flexible in that the researcher asked spontaneous, open-ended 
questions to engage in a dialogue with the participant and 
elicit her or his unfettered story about the liberation proce-
dure decision-making experience. The researcher used 
prompts such as “Could you please tell me more about that?” 
and “How did that make you feel?” to get the participant to 
elaborate on certain aspects of her or his story and obtain 
deeper and richer descriptions. The interviews lasted between 
60 and 90 min. We stopped recruiting participants and col-
lecting data once a good phenomenological gestalt was 
reached, as indicated by an “inner unity in the text” (Kvale, 
1983, p. 186), and once additional interviews only provided 
redundant information. Data were collected between May 
2011 and April 2012.
Data Analysis and Rigor
We used the hermeneutic phenomenological approach of van 
Manen (1990) in this study. This approach involved a nonlin-
ear interplay between six research activities: (a) turning to 
the nature of lived experience, (b) investigating experience 
as we live it, (c) reflecting on essential themes, (d) writing 
and rewriting, (e) maintaining a strong and oriented relation, 
and (f) balancing the research context by considering parts 
and the whole (van Manen, 1990).
Specifically, the data analysis unfolded in the following 
manner. Initially, a transcriptionist transcribed the recorded 
interviews verbatim and the first author checked the tran-
scripts for accuracy. We used the computer software program 
NVIVO 10 (Qualitative Solutions Research International, 
2012) to organize the data. All members of the research team 
independently read, reread, and reflected on all of the tran-
scripts. The research team included one researcher who was 
proficient in hermeneutic phenomenological methodology 
and other researchers who were experts in MS or disabilities. 
Two other members of the research team were research assis-
tants. Drs. Murray and Ploughman independently identified 
preliminary themes in the transcripts by using a selective 
approach and moving back and forth between elements of 
the text and the whole text.
After the initial analysis, we held research team meetings 
to discuss the preliminary themes. On the basis of phenom-
enological reflection using the four existentials (i.e., lived 
body, lived time, lived space, and lived human relation), the 
first author, Cynthia Murray, took the lead in writing, rewrit-
ing, and refining the themes identified. For instance, Murray 
further elucidated, via phenomenological refection, that 
some of the participants perceived their bodies as unstable 
(lived body) and time as being of the essence (lived time), 
whereas others perceived the opposite. We reached a unani-
mous agreement on the themes through discussion.
To attain rigor, we used verification strategies (Meadows 
& Morse, 2001; Morse, Barrett, Mayan, Olson, & Spiers, 
2002). The specific verification strategies used included 
investigator responsiveness, methodological coherence, con-
current data collection and analysis, and sampling suffi-
ciency. We remained open and listened to the data. We put on 
hold our prior knowledge about the phenomenon of interest 
(Meadows & Morse, 2001) and abandoned ideas that were 
not supported by the data. Our research question, methods, 
and analytical procedures were congruent with each other, 
and we maintained an audit trail of the research process. We 
included researchers and clinicians with expertise in MS, 
disabilities, or qualitative methodology on the research team. 
Data collection and analysis were concurrent. We continued 
to collect data and recruit participants, with first-hand knowl-
edge and lived experiences of the phenomenon under inves-
tigation, until redundancy occurred and there was a gestalt in 
the text. All of the team members ensured that the findings fit 
the data.
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Findings
The data analysis revealed two distinct main groups of peo-
ple: “embracers of the liberation procedure” (n = 9) and 
“waiters” (n = 6). Depending on the timing of their decision 
to undergo the procedure, we subdivided the embracers of 
the liberation procedure into “early embracers” and “late 
embracers.” Next, we discuss each main group and subgroup 
in succession.
Embracers of the Liberation Procedure
All embracers of the liberation procedure endorsed 
Zamboni’s treatment. However, the timing of their endorse-
ment varied: Seven individuals decided to undergo the pro-
cedure immediately, if possible, while two followed a longer 
and more complex decision-making path before reaching 
their ultimate decision. We describe these early and late 
embracers in the following sections.
Early embracers. We discovered three themes in the stories of 
the early embracers. Specifically, the themes were as fol-
lows: jumping at a promising opportunity to get better, des-
perately trying to ascend to a better quality of life, and having 
no regrets (see Table 1).
Jumping at a promising opportunity to get better. While watch-
ing the W5 program titled “The Liberation Treatment: A 
Whole New Approach to MS” (Favaro & St. Philip, 2009), 
the early embracers felt a surge of hope and excitement. The 
program (Favaro & St. Philip, 2009) roused them and led 
them to believe that a new treatment or cure for MS had been 
found. For the early embracers, the new approach to MS was 
so convincing that they jumped on it, as depicted in the fol-
lowing excerpt:
I saw it on TV actually. It seemed like promising news to 
everybody . . . They were telling a big breakthrough for MS . . . I 
said, “Finally there’s a cure for MS.” . . . And all of a sudden, 
boom, I said, “I’m going to jump on it then ‘cause everyone . . . 
got feelings and that back in their hands, their legs, their feet, and 
. . . some people are actually getting out of wheelchairs.” . . . It’s 
bringing a lot of hope to people.
Another participant stated the following:
Dr. Zamboni said that his wife was just starting to show the signs 
of MS and . . . [that] the procedure . . . stopped [it] . . . right in its 
tracks. [I said,] “I’m going to walk!” . . . The more I heard [the 
W5 show], the more excited I got . . . I was saying [I want] ten 
pairs of high-heeled shoes . . . [and] I want to dance until flames 
. . . [come] out of them. I was right hyped-up, right excited. [I] 
couldn’t wait to go.
For the early embracers, the liberation procedure seemed 
like a promising opportunity to get better. In the eyes of these 
participants, Zamboni’s procedure was a credible treatment 
for MS that made intuitive sense to them. For instance, one 
participant thought that the Zamboni procedure made sense 
to her because it was explained in the W5 episode (Favaro & 
St. Philip, 2009) as being akin to a clogged sink that needed 
to be drained. She voiced the following:
The way they were explaining it . . . like a clogged sink and the 
blood was clogged to your brain and your blood was probably 
doing the damage. It made sense what they were talking about.
For the other early embracers, the liberation procedure 
seemed logical according to their knowledge about coronary 
angioplasty. As expressed in the following quotation, they 
did not see the difference between coronary angioplasty and 
angioplasty of the jugular and/or azygos veins:
That’s like if people got a blockage in your heart . . . that’s done. 
What’s the difference with a blockage in my neck [that] they 
can’t touch my neck?
The fact that the liberation procedure was the topic of 
scrutiny for the reputable W5 investigative journalists 
lent legitimacy to the procedure. Indeed, several of the 
early embracers interpreted the information provided in 
the W5 program (Favaro & St. Philip, 2009) as “there’s 
enough science behind this.” One participant wondered 
the following:
They’re saying there’s not enough study done about it. What 
[more] do they need? . . . They know that the blockage is there. 
They know that the MS patients got them.
While contemplating how researchers were stating that 
the research performed till date on the procedure was incon-
clusive, a participant commented as follows:
Table 1. Themes Identified in the Participants’ Stories of 
Decision Making Regarding the Liberation Procedure.
Participant group Theme
Early embracers Jumping at a promising opportunity 
to get better
Desperately trying to ascend to a 
better quality of life
Having no regrets
Late embracers Greeting the liberation procedure 
with skepticism
A last-ditch effort
Risking everything
Waiters Putting the liberation procedure 
under the microscope
Skeptically refusing to jump or stay 
on the bandwagon
Not wanting to rock the boat
Waiting for credible research results
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I think they should let it go and pass through regardless because 
it’s bettering people’s lives.
On further exploration of their understanding of Zamboni’s 
theory regarding the etiology and treatment of MS, the early 
embracers offered vague explanations of both the theory and 
the Zamboni procedure itself. This was the case even though 
all but two of them had already undergone the procedure. An 
early embracer narrated the following:
On the way down to the OR, . . . I was getting dizzy, and on the 
way back up, . . . I wasn’t getting dizzy at all. I guess it was the 
iron floating around in the brain cavity or whatever. That’s what 
the fellow [Zamboni] who came up with it said . . . The iron in 
the brain cavity is a bad thing. So I’m just assuming maybe 
that’s what happened. They opened up the cavity [and] the 
pressure came off my head . . . I don’t have like pressure on my 
head anymore.
All five female early embracers were convinced that the 
liberation therapy would relieve some of their MS symptoms, 
but it would work better for those who were newly diagnosed 
or had mild symptomatology. To them, it was difficult, if not 
impossible, to heal some of the damage done to the body. As 
a case in point, one woman deemed the following:
Over the years, there’s been some damage done that probably 
won’t come back.
Conversely, the male early embracers were under the 
impression that the liberation procedure would work equally 
well for everyone, because, in effect, it was a cure. For exam-
ple, when asked to clarify whether or not he believed that the 
Zamboni treatment was a cure, one man responded in the 
following way:
Interviewer (I): Do you think it’s a cure?
Participant (P): Everyone says no, but I think personally myself, 
I think yes. I really do think yes . . . I think that someday I’m just 
going to run . . . That’s how much I believe in it.
The liberation procedure was a promising opportunity 
for the early embracers in another way. The procedure not 
only appeared to be a logical, legitimate therapy for MS 
but also seemed to be a simple and safe treatment. The 
early embracers believed that the procedure was com-
pletely risk free, with the exception of two participants, 
who pointed out that all medical procedures have inher-
ent risks. Nevertheless, they judged any risk of adverse 
events associated with the liberation procedure to be very 
small. The other early embracers took it for granted that 
there was no risk of adverse outcomes. One participant 
asserted,
It’s not going to harm you . . . It’s got no complications . . . The 
procedure is a very simple procedure. There was nothing to it.
They thought this was particularly true if a stent was not 
implanted. This was exemplified in the following 
quotation:
So I don’t see any risks. Like I’m pretty sure they know what 
they’re doing . . . Now, if I had to get stents, maybe I’d be a bit 
nervous, but I don’t see any risks, and if anything is going to 
come out of this, it’s going to be positive.
Desperately trying to ascend to a better quality of life. Together 
with sharing similar views of, and reactions to, the portrayal 
of the liberation procedure as a novel treatment for MS, the 
early embracers all had advanced or unstable MS disease. In 
the preprocedural period, among the seven early embracers, 
two had difficulty in walking unassisted, two used a cane, and 
three used a wheelchair or motorized scooter. Given their 
relatively advanced stage of disease or unstable situation, the 
early embracers felt that they were desperate for a cure or at 
least something to relieve their suffering or to reverse their 
disease to an earlier state, at which they were more indepen-
dent and coped better with MS. Participants illustrated these 
points with comments such as the following:
If I could . . . go back to the way that I was 5 years ago, it would 
be worth every penny
and
After so many years, you’d almost try anything to give you a bit 
of a break . . . After a while [of] suffering so much, any kind of 
hope at all you’re going to try it.
In the midst of a fast downward spiral or feeling at rock 
bottom, the liberation procedure represented hope or a 
chance for a better quality of life and, at a deeper level, life 
itself. The early embracers reckoned they had “nothing to 
lose” in their attempts. For instance, one person shared the 
following comment:
I had nothing to lose . . . I am grabbing at straws, but I looked at 
this as a better quality of life . . . To me, I’m right down here at 
the bottom, and the only way to go is up!
Another early embracer’s account was as follows:
You got nothing to lose . . . In the last couple of years, my health 
was just going downhill, downhill, and downhill. Like the first 
. . . 12 years when I had MS, I never used to have a cane, but 
[since] the last couple of years, I started dragging my feet . . . 
and everything started going downhill . . . [I would do] anything 
for hope and hope was there and I wanted to go. Yeah, I was 
starting to trip over my feet worse, and . . . I started to hold onto 
that cane for dear life.
The early embracers thought that nonstent angioplasty of 
the jugular and/or azygos veins was relatively safe. 
Nevertheless, when posed with hypothetical questions about 
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the extent of risk they would be willing to take, it was evident 
that these participants would gamble their lives for an oppor-
tunity to get better. An early embracer recounted,
They’ve had a couple of deaths too. I’ve heard that . . . but I’d 
take a chance . . . Somebody said . . . “Would you take a chance?” 
I said, “Indeed I would!”
In addition, take, for instance, the following exchange 
between one early embracer and the interviewer, who tried to 
determine the extent of mortality risk that the participant 
would take to undergo the experimental procedure:
I: What about if they said there’s a chance that you’ll die?
P: Oh yeah. No, I don’t think it would deter me.
I: How much of a risk are you willing to take in terms of num-
bers, fifty–fifty?
P: Oh, yes definitely. You know, I really don’t think I’d 
hesitate.
On a similar note, another early embracer estimated that 
the worst case scenario that could possible arise from under-
going the liberation procedure was not death or a stroke, but 
the continuation of his life in a wheelchair. Echoing these 
sentiments, another early embracer did not fear the proce-
dure itself; rather, he was more afraid of the consequences of 
not proceeding with it. All of the early embracers who men-
tioned whether or not they would have agreed to a stent indi-
cated that they would have given consent for it, despite their 
knowledge of the risks associated with their use.
All but two of the early embracers quickly set about to 
undergo the liberation procedure in Poland, Costa Rica, or 
the United States. In the case of the two exceptions, the par-
ticipants could not afford the high cost of traveling abroad 
for the procedure, although if they could, they would “jump 
at the chance,” as phrased by one of these two early embrac-
ers. One participant in this study who underwent the Zamboni 
treatment paid $6,300 for the procedure alone. Others noted 
that they incurred between $14,000 and $20,000 in total 
expenses to undergo the procedure outside of the country.
Having no regrets. At the time of the interviews, the early 
embracers who underwent the liberation procedure (n = 5) 
reported several favorable postoperative outcomes. All of 
them gave credit to the procedure for improving their overall 
mental well-being. Furthermore, all of them either mentioned 
better motor function (n = 4) and/or improved sensation in 
their extremities (n = 4). Two of these early embracers main-
tained that their circulation was enhanced, whereas another 
two individuals cited more energy and less fatigue. These par-
ticipants also noted greater bladder control (n = 1), less vertigo 
(n = 1), and fewer headaches (n = 1). Among the three early 
embracers who received preoperative disease-modifying 
therapies, one stopped taking the medications after the libera-
tion procedure.
Two early embracers reported unfavorable outcomes. One 
developed a thrombosis that was likely induced by the libera-
tion procedure. In the second case, the participant attributed 
a relapse of symptoms after the first procedure to the fact that 
he ultimately never received a stent, even though the doctor 
performing the procedure tried to insert one. The participant 
subsequently underwent the procedure again, being the only 
early embracer who underwent the procedure twice.
All of the participants in this study saw the W5 program 
(Favaro & St. Philip, 2009), either on television or the Internet. 
The program featured a man who was formerly in a wheel-
chair but could suddenly walk perfectly after the liberation 
procedure. Despite their less-than-miraculous results, the early 
embracers were generally very pleased with the procedure and 
their outcomes. None of them regretted her or his decision to 
undergo the liberation procedure, and all said they would 
highly recommend it to others. Because of the presence of less 
stiffness in her hands and slightly better balance compared 
with her condition before the procedure, one early embracer 
proclaimed the following to other individuals with MS:
Oh my God! I wouldn’t change my decision . . . Yes, go and have 
it done because I’m one hundred percent [better] to what I was 
. . . Mine worked perfect.
The early embracers surmised that exercise was necessary 
to walk again without difficulty or assistance. In fact, the two 
early embracers who reported the greatest physical improve-
ments began working out actively on their return to Canada. 
Another early embracer figured she would be able to walk 
again with physiotherapy after medical treatment for her 
thrombosis.
Late embracers. In the wake of the W5 program (Favaro & 
St. Philip, 2009), some of the embracers of the procedure did 
not readily decide to have Zamboni’s treatment. Two partici-
pants fell into the category of late embracers because of the 
later timing of their decision to proceed with Zamboni’s 
treatment. We identified three themes in the stories of the late 
embracers: greeting the liberation procedure with skepti-
cism, a last-ditch effort, and risking everything (see Table 1).
Greeting the liberation procedure with skepticism. In contrast 
with the hope and excitement experienced by the early embrac-
ers, the two late embracers were skeptical as they watched or 
heard about the W5 show (Favaro & St. Philip, 2009). Skepti-
cism emerged, for instance, in the following quotation:
They [supposedly] had the big cure . . . I was a big skeptic.
For months, the late embracers were staunchly opposed to 
the liberation procedure. They were well aware of glorified 
stories of so-called cures in the past, and, at first, Zamboni’s 
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theory and therapy failed to make any sense to them. A late 
embracer described her initial reaction to the W5 broadcast 
(Favaro & St. Philip, 2009) as follows:
I watched the W5 special and . . . I was thinking, “No, there is 
something not right about this.” I spoke to . . . Dr. [name] about 
it . . . because it just didn’t make sense to me. . . . It wasn’t 
logical.
The late embracers encountered red flags warning them 
against undergoing the procedure, which fueled their 
skepticism. For example, because of her university back-
ground, one late embracer was cognizant of the fact that 
the theory and accompanying procedure lacked scrutiny 
and study by the global scientific community and that 
consequent, rigorous research laid ahead. In the following 
passage, a late embracer remarked about red flags on 
which he stumbled:
His wife was . . . after having it done and . . . I was talking to him 
about it. [He said,] “Wife just came back and she’s going down 
again now.” Okay, red light there. “Why is she going down 
again?” “Well, they kind of collapsed in again. She’s going to 
get them blown out again.” Okay, red light.
A last-ditch effort. For the late embracers, the shadow of 
doubt cast over the liberation procedure did not dissipate 
for months. When faced with a pivotal situation, they 
changed their skeptical stance toward the procedure. One 
late embracer started to hear too many good stories to 
ignore, and he came to the realization that he was just 
dying and living a hellish existence. He explained the 
following:
[I was] just getting sicker and sicker and just watching . . . life 
go on . . . I just couldn’t take it no more. [It’s] do or die because 
it’s a hellish existence . . . The drugs [are] . . . doing nothing. You 
know, it’s not slowing [MS] down . . . I’ve got a bit of hope now. 
I’m not just dying . . . There’s nowhere to go but up anyway. 
Instead of waking up worse every day, now I’m getting a bit 
better.
The other late embracer’s circumstances included a sharp 
turn for the worse in her health status. As illustrated by the 
following statements, she found herself in the same desper-
ate, rock-bottom position as the other embracers, where there 
was nowhere to go but up. The liberation procedure gave 
them a glimmer of hope to either stave off death or enhance 
their quality of life. One late embracer provided these 
insights:
My life had spiraled downward . . . I was in a wheelchair. I had 
very little quality of life at that point . . . I am still alive, but . . . 
I was in bed a lot . . . The fatigue was just so debilitating . . . I 
was just there. So everybody was saying to me, “Give it a try 
. . . What do you have to lose?” And finally . . . one day I just 
said, “You know what? I really don’t have a whole lot to lose. So 
why not?” . . . It comes down to desperation.
On reflection, the late embracers came around to the idea 
of undergoing the liberation procedure. Neither of them 
thought it was a cure for MS, but they believed that it could 
alleviate some of their MS symptoms. Similar to the female 
early embracers of the procedure, the late embracers sur-
mised that once some of the damage was done, it was perma-
nent. The late embracers chimed in with their early 
counterparts in calling for publicly funded health care cover-
age for the procedure to treat CCSVI, regardless of whether 
or not the individual had MS. One late embracer simply 
stated the following:
MS related or not, if you have blocked veins, open them.
The late embracers highly recommended the procedure to 
other individuals with MS. However, they were also con-
vinced that exercise was key to any recovery.
Risking everything. In sharp contrast to the belief held by 
the early embracers that there was little or no risk involved 
in the liberation procedure, the late embracers perceived 
that it could be very dangerous and that they were pio-
neers of the system. Both late embracers knew about the 
Canadian case of Mahir Mostic, who was in the news 
because he apparently died from postliberation treatment 
complications (“Ont. man dies,” 2010). In fact, one late 
embracer knowingly underwent the procedure in the same 
facility as Mr. Mostic shortly after his death. She recalled 
the following:
I went to South America to have that procedure done right at the 
height of the controversy . . . And it was just touted as being 
dangerous. I mean [when] I went to Costa Rica . . . after that 
poor man who died. . . . It was the same facility . . ., the same 
everything . . . You just get desperate and you take those chances, 
and you hope to God it . . . [doesn’t] happen to you.
Despite their knowledge of the potential dangers associ-
ated with the liberation procedure, including the risk of 
death, the late embracers divulged that they were willing to 
accept the risk of undergoing the procedure. In fact, one late 
embracer ended up undergoing the procedure on two sepa-
rate occasions and assuming the risk twice because she 
thought her first procedure was botched. The other late 
embracer emphatically stated the following:
P: Do or die!
I: So if they told you, “Okay, it’s [a] fifty–fifty [chance] you 
could die in this procedure or not,” how much would you risk?
P: I’ve been doing nothing but getting worse over 5 years. Yeah, 
do or die.
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On a final note regarding the late embracers, one of them 
reported an increase in her quality of life after the liberation 
procedure, an improvement in her gross motor function, and 
more energy. Together with an improvement in his motor 
performance, the other late embracer also experienced less 
paresthesia and “brain fog.”
Waiters
In this study, six of the participants followed a different deci-
sion-making path compared with the early or late embracers 
of the liberation procedure. On the basis of their experience, 
we categorized these six participants as “waiters.” The data 
analysis revealed four themes in the case of the waiters: put-
ting the liberation procedure under the microscope, skepti-
cally refusing to jump or stay on the bandwagon, not wanting 
to rock the boat, and waiting for credible research results (see 
Table 1).
Putting the liberation procedure under the microscope. The 
waiters also took notice of the W5 program (Favaro & St. 
Philip, 2009) because news of the liberation procedure 
spread rapidly throughout the MS community. The television 
broadcast (Favaro & St. Philip, 2009) on the procedure 
piqued their interest, and they were intrigued by the possibil-
ity of a major breakthrough in the treatment of MS. The pro-
gram (Favaro & St. Philip, 2009) was somewhat compelling 
to them, and they tended to be swayed toward it.
The W5 program (Favaro & St. Philip, 2009) generated a 
great amount of hope and excitement among several indi-
viduals in the MS community. Early embracers of the libera-
tion theory and procedure quickly took steps toward 
undergoing the procedure, if possible. Meanwhile, the wait-
ers seriously considered the procedure for themselves. As a 
matter of fact, two of these participants had booked proce-
dures abroad. At this time, equipped with their postsecond-
ary education, the waiters began to put the liberation theory 
and procedure under the microscope. For instance, one read 
and critiqued the original research article by Zamboni and 
his colleagues (Zamboni, Galeotti, Menegatti, Malagoni, 
Gianesini, et al., 2009). She explained the following:
In that [research] article I read, it was only for 18 months, and 
then some of their symptoms came back. And half of the people 
who had the vein opened, it reclosed as soon as they took it out 
. . . unless they had a stent put in . . . I read that article so I knew 
the numbers I was working with . . . That’s not very many people 
that they tested.
Skeptically refusing to jump or stay on the bandwagon. For all 
the waiters, on closer inspection, skepticism began to creep 
into their thoughts about the theory and procedure. Their dis-
cussions with other individuals, such as health care profes-
sionals and other MS patients, sowed seeds of doubt about 
the procedure. One waiter asserted the following:
I’m not going to hop on board just because everyone else is 
doing it and hope for the best . . . From the information that I was 
given from Dr. [name], I just didn’t feel that it was enough to go 
by to jump on the wagon and say, “Let’s go for it.”
At this point in time, the waiters began to change their 
minds about the procedure, and the two individuals who had 
made arrangements for the procedure canceled their plans. 
One of these two individuals related the following:
[It’s like] snake oil . . . They can say anything works . . . I met 
this lady [with MS] and [we] talked about the liberation 
treatment and she said, “I had it done as soon as I was diagnosed.” 
And I said, “How did it help you?” She said, “Well, now I’m 
using a walker.” . . . [She was] just hoping to halt the progression 
of the disease and it didn’t . . . After hearing a bit about it and 
finding out a bit more information, I said, “This is not as good as 
they say it’s going to be.” So that’s why I changed my mind.
Not wanting to rock the boat. Although they wished it was a 
cure, the waiters ultimately took the stance of health care 
professionals and researchers, who cautioned MS patients 
against undergoing the experimental procedure. From the 
vantage point of the late embracers and waiters, the libera-
tion procedure entailed a high level of risk, including the risk 
of stroke and death. However, one distinction between the 
two groups was that the waiters were not prepared to accept 
the risk associated with the new procedure. Given that the 
waiters were comparatively well and their conditions were 
stable, they concluded that it was best to not “rock the boat,” 
as summed up by one waiter. These participants used other 
similar expressions, such as “Don’t fix what’s not broken” 
and “Leave well enough alone.” The following excerpt eluci-
dates this perspective:
Why am I going to try and fix something right now that’s really 
not broken because after I got . . . stable, I haven’t had an issue 
since then, not one flick? So I’m not going to rock the boat to try 
something.
Having said that, the waiters empathized with the embrac-
ers and stated that they would act in the same manner as the 
embracers if their condition deteriorated. In other words, 
they could relate to the expression “do or die.” One waiter 
stated the following:
Oh, there’s no possible way I could have lived the first 6 weeks 
the way I was, absolutely not. If I . . . had some kind of paralysis, 
major paralysis, it wouldn’t take me long to try anything because 
I’m such an active person, and for me to come down to that level 
. . . would be catastrophic to me.
Waiting for credible research results. The waiters took stock of 
their own situation, and the picture that emerged was one of 
patience. Unlike the embracers of the procedure, who the 
waiters deemed had more severe symptoms and required a 
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decision more rapidly, the waiters gathered that they had 
time to wait for the follow-up research results they craved. 
They believed that the procedure could be a hoax, and, as 
exemplified in the quotations that follow, they were comfort-
able with their final decision to not undergo the procedure, 
thereby letting others be the proverbial “guinea pigs”:
I was quite comfortable with . . . [the] decision I had made. 
Myself and my husband . . . said we’d wait and see. . . . [We’d] 
wait for some [study] results to come in
and
I’ll question on where the [local] study is . . . “How far are they? 
. . . [Is] there any kind of information?” . . . I’m not going to be 
the first one to jump on it and say, “Here, use me as a guinea 
pig.”
Discussion
Health experts such as Pullman et al. (2013) questioned the 
rationale of the CCSVI/liberation procedure phenomenon. In 
the present study, in regard to decision making pertaining to 
the liberation procedure, we identified two main groups of 
people: (a) embracers of the liberation procedure and (b) 
waiters. We subdivided the embracers into early and late 
embracers. A distinguishing characteristic of the late embrac-
ers and waiters was skepticism, whereas desperation was a 
common core or essence that set both subgroups of embrac-
ers apart from the waiters. We discuss both of these defining 
characteristics herein; however, let us first consider the skep-
ticism, or its absence, in the stories of the participants.
As the late embracers and waiters delved into their narra-
tives, it was clear that skepticism came on the heels of hear-
ing about the liberation procedure sooner or later. Participants 
raised the idea that the liberation procedure could be a hoax 
or akin to snake oil, which is a “substance with no real 
medicinal value sold as a remedy for all diseases” (Pearsall, 
2013, “Definition” section, para. 1). This is consistent with 
the views expressed in other publications on the liberation 
procedure as a treatment for MS (Oger & Alkhajawah, 2010) 
and on stem cell transplantation (Dedmon, 2009) and CAM 
(Bausell, 2007) for a variety of diseases, including MS.
With recognition that further research was needed before 
the procedure could either receive medical sanction or rejec-
tion, the waiters looked on as others became human guinea 
pigs. Other authors and researchers observed that patients 
who choose to journey into uncharted medical waters view 
themselves as pioneers (Caulfield & Zarzeczny, 2012; 
Rachul, 2011). However, the staff at clinics that offer these 
unproven treatments have not presented their results for peer 
review (Caulfield & Zarzeczny, 2012), which could be unbe-
knownst to the general public. The waiters thought that the 
liberation procedure could potentially play havoc with their 
bodies. This finding is not surprising, given the literature on 
the embodiment of MS. For instance, Gardner and Gronfein 
(2006) exposed in their research that MS patients armor their 
bodies in public for protection because they perceive their 
bodies as “fragile and unpredictable” (p. 83).
In contrast, the early embracers jumped at what they saw 
as a promising opportunity to get better, with no hint of skep-
ticism in their stories. The W5 program (Favaro & St. Philip, 
2009), which featured anecdotal evidence of successful lib-
eration procedures, was very appealing to them. Explanations 
regarding CCSVI and its accompanying procedure made 
sense to them, and they deemed that the procedure was, for 
all intents and purposes, harmless. In a similar fashion, a 
major finding of Pedersen’s (2013) recent phenomenological 
analysis of interviews with 46 Danish adults who use alterna-
tive medicine was the participants’ belief that these treat-
ments can at least do no harm. Moreover, the appealing 
nature of the anecdotal accounts is in line with two studies 
suggesting that MS patients are strongly influenced by anec-
dotal evidence in their CAM-related treatment decisions 
(Berkman, Pignotti, Cavallo, & Holland, 1999; Olsen, 2009).
Other research demonstrated that individuals with MS 
would rather receive health information on MS in general 
from an “expert patient” (Malcomson, Lowe-Strong, & 
Dunwoody, 2008, p. 671) or from the Internet, including 
social media websites (Marrie, Salter, Tyry, Fox, & Cutter, 
2013), than from a nurse or other health care professional. 
Indeed, in a study performed by Rachul (2011) that included 
MS patients who elected to undergo stem cell therapy, 
although some of the patients tried to obtain peer-reviewed 
articles in their search for information, most thought that 
they were well informed on the basis of testimonials of other 
patients. Furthermore, psychological research has long 
informed us that narratives are more powerful relayers of a 
message than any other format, thus leading individuals to 
place greater weight on narratives than, for instance, on sta-
tistics (Shaffer & Zikmund-Fisher, 2013).
Skepticism might have been absent from the descriptions 
of the experience from the vantage point of the early embrac-
ers for another reason. The belief that sufficient research had 
already been conducted in support of the liberation proce-
dure surfaced in several of their stories. This might have 
allayed any skepticism they felt. Other researchers reported 
the misunderstanding of scientific research and skepticism or 
criticism of evidence-informed health care among patients 
elsewhere (Carman et al., 2010; Rachul, 2011).
Goldberg (2011) raised the alarm that science is at a cross-
roads between fact and fiction. Numerous factors never seen 
before (e.g., outpourings of public support for scientifically 
uncorroborated medical practices or even scientific fraud) 
are currently threatening the integrity of research. Other 
authors discussed an emerging threat of “Internet-based 
practice” (Reekers, 2011, p. 128) or the possibility of public 
revolts against evidence-informed practice if it got in the 
way of treatments (Carman et al., 2010). Although the 
Internet and social media platforms might play a larger role 
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in health care in the future, as outlined in Hawn’s (2009) 
social commentary titled “Take Two Aspirin and Tweet Me 
in the Morning,” scholars noted several dangers regarding 
the Internet and social media from a health perspective (Lau, 
Gabarron, Fernandez-Luque, & Armayones, 2012). For 
example, researchers implicated YouTube videos in the nor-
malization of self-harming behaviors (Lau et al., 2012).
It is particularly alarming that some educated individuals 
who occupy powerful positions in society have, perhaps 
unwittingly, turned their backs on science. Pullman et al. 
(2013) discussed the case of a Canadian Member of 
Parliament who apparently equated scientific and anecdotal 
evidence for the liberation procedure. An older example 
involved a judge in Italy who ordered doctors at a local hos-
pital to prescribe Di Bella’s treatment, which is an unverified 
miracle cure for various diseases, including cancer, MS, and 
Alzheimer’s disease (Abbasi, 1998).
For the early and late embracers alike, desperation lurked 
behind their decision to undergo the liberation procedure. 
This finding mirrors research in the area of CAM for MS 
patients (Hussain-Gambles & Tovey, 2004; Rachul, 2011). 
An examination of qualitative research on the experience of 
living with MS provides some clues that could help in 
explaining these findings. In particular, qualitative research 
brought to the fore the importance of trying to maintain 
power (Olsson, Lexell, & Söderberg, 2008), being proactive 
(Malcomson et al., 2008), and using hope in coping with 
chronic dread and an unpredictable disease (Kirkpatrick 
Pinson, Ottens, & Fisher, 2009). Also, the desperation that 
was rampant in the accounts of all of the embracers and the 
willingness of the late embracers to accept a perceived high 
degree of risk are in keeping with the terror management 
theory (TMT). Studies in the area of TMT have demonstrated 
that individuals, particularly those with an external locus of 
control, engage in high-risk behaviors when faced with 
thoughts of their mortality (Greenberg & Arndt, 2012; Miller 
& Mulligan, 2002).
In closing, we need to consider the findings of this study 
in light of some limitations. First, the participants in this 
study consented to interviews that lasted between 60 and 90 
min. There might have been individuals who heard about the 
study and decided not to participate because of time con-
straints or other reasons. It is possible that nonparticipants 
might have experiences different from those of the 15 par-
ticipants in this study. A second limitation was that the study 
findings were based on one interview with each participant. 
Further interviews could have shed a different or better light 
on the experience. Nevertheless, we acknowledge that a 
good interpretation is never final; rather, it keeps the conver-
sation going (Jardine, 1992). In this spirit, we recommend 
further qualitative research in this area to continue the dia-
logue. Together with the findings of this study, this might 
translate into reflective practice that can better equip nurses 
and other health care professionals to help MS patients in 
making informed decisions about the liberation procedure.
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